(1)
Perioperative Immune Checkpoint Inhibitors Plus Chemotherapy Versus Chemotherapy Alone in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: A Systematic Review and Meta-Analysis. Nepal J Epidemiology 2026, 16 (1), 1412-1423. https://doi.org/10.3126/nje.v16i1.92321.